Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $22.5300 (-3.35%) ($21.8700 - $23.1600) on Wed. Apr. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6% (three month average) | RSI | 57 | Latest Price | $22.5300(-3.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 1.3% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) ARKG(57%) IWO(57%) XBI(56%) IBUY(54%) | Factors Impacting EDIT price | EDIT will decline at least -3% in a week (0% probabilities). VIXM(-30%) VXX(-14%) UUP(-14%) TBT(-5%) IYT(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3% (StdDev 6%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $22.19(1.53%) | 10 Day Moving Average | $21.23(6.12%) | 20 Day Moving Average | $20.66(9.05%) | To recent high | -31.3% | To recent low | 51.4% | Market Cap | $1.399b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |